<DOC>
	<DOC>NCT01819935</DOC>
	<brief_summary>The purpose of this non-interventional, retrospective study of existing data is to evaluate clinical outcomes related to Methicillin-resistant Staphylococcus aureus hospital based pneumonia by treatment and among subpopulations.</brief_summary>
	<brief_title>Clinical Outcomes of Methicillin Resistant Staphylococcus Aureus (MRSA) Hospital-Based Pneumonia</brief_title>
	<detailed_description>All patients meeting inclusion/exclusion criteria from inpatient database from 1/1/02-9/30/10.</detailed_description>
	<mesh_term>Pneumonia</mesh_term>
	<mesh_term>Staphylococcal Infections</mesh_term>
	<mesh_term>Linezolid</mesh_term>
	<mesh_term>Vancomycin</mesh_term>
	<mesh_term>Methicillin</mesh_term>
	<criteria>MRSA and pneumonia cases by ICD9 code identification. Diagnosis included during inpatient stay. Treatment initiation in hospital. Death of discharge within 3 days of treatment initiation. Exposure to other treatments with MRSA activity.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>December 2013</verification_date>
	<keyword>MRSA. pneumonia</keyword>
	<keyword>outcomes</keyword>
</DOC>